iCoreConnect Inc. Common stock Cash Flow Conversion Efficiency

Latest as of September 2024: 0.083x

iCoreConnect Inc. Common stock cash flow conversion efficiency. Based on the latest financial reports, iCoreConnect Inc. Common stock (ICCT) has a cash flow conversion efficiency ratio of 0.083x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-250.46K) by net assets ($-3.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of iCoreConnect Inc. Common stock (2006–2023)

Cash flow conversion efficiency of iCoreConnect Inc. Common stock from 2006 to 2023. This chart illustrates how iCoreConnect Inc. Common stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ICCT stock price and chart for real-time trading data and today's change.

iCoreConnect Inc. Common stock Cash Flow Conversion Ratio Explained

iCoreConnect Inc. Common stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

iCoreConnect Inc. Common stock Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of iCoreConnect Inc. Common stock ranked by their cash flow conversion efficiency. Also see iCoreConnect Inc. Common stock market cap and net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Casa Minerals Inc
V:CASA
0.040x
Dogness International Corp Class A
NASDAQ:DOGZ
-0.017x
Taoping Inc
NASDAQ:TAOP
-0.131x
IT Tech Packaging Inc
NYSE MKT:ITP
0.010x
Schroder UK Mid Cap Fund PLC
LSE:SCP
0.003x
Shin Hwa Silup
KO:001770
-0.042x
Eastfield Resources Ltd
V:ETF
-0.094x
Rebosis Property Fund Ltd
JSE:REA
-0.010x

Annual Cash Flow Conversion Efficiency for iCoreConnect Inc. Common stock (2006–2023)

The table below shows the annual cash flow conversion efficiency of iCoreConnect Inc. Common stock from 2006 to 2023. Review free cash flow generation of iCoreConnect Inc. Common stock to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2023-12-31 $4.44 Million $-8.82 Million -1.986x -490.21%
2022-12-31 $-2.50 Million $-1.27 Million 0.509x +117.66%
2021-12-31 $1.01 Million $-2.90 Million -2.881x -242.62%
2020-12-31 $-628.94K $-1.27 Million 2.020x +156.35%
2019-12-31 $465.00K $-1.67 Million -3.585x -274.42%
2018-12-31 $-958.00K $-1.97 Million 2.055x +36.79%
2017-12-31 $-1.18 Million $-1.77 Million 1.503x +94.20%
2016-12-31 $-2.26 Million $-1.75 Million 0.774x +521.11%
2015-12-31 $-12.96 Million $-1.61 Million 0.125x -3.24%
2013-12-31 $-12.79 Million $-1.65 Million 0.129x +86.80%
2012-12-31 $-7.92 Million $-545.84K 0.069x -86.09%
2011-12-31 $-2.57 Million $-1.27 Million 0.495x +2.49%
2010-12-31 $-3.56 Million $-1.72 Million 0.483x +117.94%
2009-12-31 $941.34K $-2.54 Million -2.694x -387.89%
2008-12-31 $4.11 Million $-2.27 Million -0.552x -21.84%
2006-12-31 $7.46 Million $-3.38 Million -0.453x --

About iCoreConnect Inc. Common stock

NASDAQ:ICCT USA Health Information Services
Market Cap
$3.23 Million
Market Cap Rank
#29332 Global
#6005 in USA
Share Price
$1.56
Change (1 day)
+0.00%
52-Week Range
$1.56 - $1.56
All Time High
$12.28
About

iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history… Read more